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1990.-Erythropoietin (EPO) production in response to hy- 
poxic hypoxia is known to be attenuated by simultaneous 
hypercapnia. This study aimed to investigate whether this 
inhibitory effect of hypercapnia is 1) a direct effect of carbon 
dioxide or mediated by changes in pH or bicarbonate, 2) affects 
also carbon monoxide hypoxia, and 3) influences either the 
synthesis and release of EPO or the mechanisms by which 
hypoxia triggers an increase in EPO production rate. We found 
that EPO formation in mice exposed to normobaric hypoxia 
(8% 02) or to carbon monoxide (0.1%) was reduced by 30 and 
42% when animals were simultaneously exposed to hypercapnia 
(7% CO& by 35 and 38% when subjected to metabolic acidosis 
(NH&l), and unchanged when subjected to metabolic alkalosis 
(NaHC03). In animals exposed to brief hypoxia (15 min) and 
subsequent normoxia (2 h), metabolic acidosis did not affect 
EPO levels when initiated after the hypoxic period. The results 
indicate that acidosis inhibits hypoxia-induced triggering of 
EPO formation independently of PCO~ and HC03 levels. Be- 
cause this inhibitory effect is also present during carbon mon- 
oxide hypoxia, it appears not solely due to potentiated hyper- 
pnea. Alternatively, it may result from a facilitated intrarenal 
oxygen release or a direct effect at the EPO production sites. 
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ERYTHROPOIETIN (EPO) is produced by renal peritubular 
cells in an inverse correlation with the oxygen content 
of arterial blood. This adaptation of EPO formation to 
oxygen availability appears to occur in the kidney itself 
and involves alterations in EPO gene transcription (21). 
However, the mechanisms by which changes in renal 
oxygen supply affect the production rate of EPO are 
largely unknown. 
Interestingly, the increase in serum EPO levels in 
response to diminished inspiratory oxygen tension is 
attenuated when inspiratory carbon dioxide tensions are 
simultaneously increased (1, 3, 8, 14, 20, 25, 26). This 
inhibitory effect of hypercapnia has not been fully clar- 
ified, and a number of possibilities have to be considered. 
The primary alteration in acid-base balance comprises 
an increase in PCO~ and bicarbonate levels and a decrease 
in pH, and each of these changes might affect the amount 
of circulating EPO. The increase in PCO~ and decrease 
in pH diminish the oxygen affinity of hemoglobin, and 
it has been suggested that this results in increased pe- 
ripheral oxygenation, thereby reducing the signal for 
EPO formation (14, 16, 20, 25). In addition, hypercarbia 
improves oxygen availability by increasing the ventila- 
tory response to hypoxia, which in turn enhances arterial 
Paz and oxygen saturation (3, 14, 23, 25). 
Furthermore, in a variety of models, including the 
isolated perfused kidney (22), renal cortical slices (IS), 
and isolated tubule preparations (2, 24), a protective 
effect of acidosis against hypoxic injury has been dem- 
onstrated. Although the subcellular mechanisms of this 
effect remain elusive, it is conceivable that acidosis may 
render the cells that govern EPO production less suscep- 
tible toward hypoxia. Alternatively, not only t.he signals 
inducing EPO formation but also the synthesis of the 
hormone itself or EPO clearance may be sensitive to 
acid-base changes, thereby affecting serum levels. 
In the present study, we investigated the effect of acid- 
base changes on EPO production in mice to confine these 
possible mechanisms. First, the effects of respiratory and 
metabolic acidosis were compared to evaluate whether 
EPO responds directly to changes in systemic pH or is 
related to specific effects of changes in Pco~. Miller and 
co-workers (16) and Schooley and Mahlmann (20) pre- 
viously reported an inhibition of EPO formation after 
treatment with acetazolamide, which is associated with 
metabolic acidosis. However, we have recently demon- 
strated that acetazolamide can inhibit EPO formation 
independent of changes in systemic acid-base status, 
presumably by inhibition of proximal tubular sodium 
reabsorption (6). Therefore, the effect of a systemic 
metabolic acidosis on EPO production had to be reas- 
sessed. Second, to evaluate the role of an acidosis-in- 
duced increase in ventilation for the suppression of EPO 
levels, we examined the effect of acid-base changes on 
hypoxia induced by carbon monoxide inhalation. Under 
this condition of diminished oxygen transport capacity, 
an increased ventilation cannot significantly enhance 
peripheral oxygenation. However, previous reports on 
the effect of hypercapnia on increases in EPO levels after 
reductions in oxygen-carrying capacity are conflicting; 
whereas Faura and co-workers were unable to demon- 
strate a suppression of EPO levels in anemia (8), Miller 
and Howard found a significant reduction (14). Third, 
we used a combination of short-term hypoxia and sub- 
sequent normoxia to separate an initial phase of signal 
transduction from subsequent hormone synthesis, to 
evaluate the effect of acid-base alteration on each phase. 
Our results indicate that hypoxia-induced EPO for- 
mation is inhibited by a decrease in systemic pH, irre- 
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spective of the way by which it is brought about, and 
that this inhibition affects the mechanisms triggering an 
increase in EPO formation but not hormone synthesis 
itself. 
MATERIALS AND METHODS 
Institute of Cancer Research (ICR) strain male mice 
(body wt 27-34 g) were used in this study. Animals had 
free access to standard laboratory chow and tap water 
before and during the experiments. 
Hypoxic stimulation of EPO formation. Normobaric 
arterial hypoxia or functional anemia caused by carbon 
monoxide inhalation were used to stimulate EPO for- 
mation, as described (6). In brief, animals were exposed 
for 3 h to atmospheres low in oxygen (8% 0, and balance 
N2) or normal air with added carbon monoxide (0.1%). 
Within 15 min after termination of hypoxia, animals 
were bled from the retroorbital sinus for determination 
of serum EPO levels. 
In a separate set of experiments, designed to distin- 
guish the induction of EPO formation from a subsequent 
phase of hormone synthesis, animals were exposed to 8cT 0 
0, for 5-40 min a .nd thereafter expo lsed to normoxia for 
an additional l-2.5 h before blood sampling. 
Induction of alterations in acid-base status. To study 
the effect of respiratory acidosis on hypoxia-induced 
EPO levels, animals were exposed to atmospheres of 1) 
8% 0, together with 5, 7, or 10% CO2 and balance N2 or 
2) 0.1% CO, 20% 02, and 7% COZ. Previous studies 
employing hypoxia of comparable duration and severity 
in rats or rabbits (7.5~8.8% 02) have shown that the 
addition of 5-5.6% CO2 or 10% CO2 increases arterial 
PCO~ from 15.9-27.9 to 41.4-48.1 and 70.8 mmHg and 
reduces blood pH from 7.43-7.51 to 7.30-7.37 and 7.28, 
respectively (3, 14, 25). 
Metabolic acid-base disturbances were induced by ap- 
plication of ammonium chloride (metabolic acidosis) or 
sodium bicarbonate (metabolic alkalosis). One-molar so- 
lutions of ammonium chloride and sodium bicarbonate 
were injected 50% intraperitoneally and 50% subcuta- 
neously at a dose of 10 and 20 mmol/kg body wt, respec- 
tively, immediatly before the onset of hypoxia. In those 
experiments, comprising a first interval of hypoxia and 
a second interval of normoxia, ammonium chloride was 
injected immediately before or after termination of hy- 
poxia. Control animals were treated with identical vol- 
umes of equimolar sodium chloride and simultaneously 
exposed to the respective hypoxic stimuli. 
Determination of EPO. EPO was measured in serum 
by radioimmunoassay as described (7), using a rabbit 
antiserum raised against recombinant human EPO and 
iodinated recombinant EPO (Amersham International, 
Amersham, UK) as tracer. A mouse serum pool enriched 
in EPO, prepared and calibrated by in vivo bioassay as 
described (6), was used as a standard. 
Determination of acid-base parameters. To assess the 
effect of ammonium chloride and sodium bicarbonate 
treatment on acid-base status, pH and standard bicar- 
bonate concentrations in peripheral venous blood were 
determined. Animals were anesthetized with 400 mg/kg 
bodv wt 5-ethyl-(1’-methvlpropvl)-Z-thiobarbituric acid 
(Inactin, Byk-Gulden, Constance, FRG) injected intra- 
peritoneally in a concentration of 100 mg/ml. Immedi- 
ately after onset of anesthesia they were bled from the 
retroorbital sinus into heparinized glass capillary tubes 
that were then instantly transferred to a computerized 
blood gas analyzer (IL 1304, Instrumentation Labora- 
tory, Lexington, MA) for determination of pH, Paz, and 
PCO~ with the appropriate electrodes. Oxygen saturation 
was estimated from Paz using an oxygen dissociation 
curve that was previously determined by tonometry of 
pooled mouse blood. Standard bicarbonate concentra- 
tions were calculated employing the values for pH, Pco2, 
and oxygen saturation in standard formulas. 
Statistics. Statistical analysis was performed by use of 
Student’s t test with Bonferroni’s reduction for multiple 
comparisons. P c 0.05 was considered significant. 
RESULTS 
Effect of acid-base alterations on EPOproduction under 
hypoxic hypoxia. The effect of increasing concentrations 
of carbon dioxide in the inhaled gas mixture on serum 
EPO levels induced by 3 h of normobaric arterial hypoxia 
(8% Ox) is shown in Fig. 1. Carbon dioxide led to a 
concentration-dependent suppression of EPO values. To 
investigate whether the inhibitory effect of hypercapnia 
was related to the decrease in pH or the increase in PCO~ 
or bicarbonate, we intended to 1) decrease pH without 
increasing PCO~ and bicarbonate and 2) elevate bicarbon- 
ate without decreasing pH, by inducing a metabolic aci- 
dosis or alkalosis. Therefore animals were treated with 
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TABLE 1. Peripheral venous pH and standard sodium bicarbonate concentrations 
in mice 1 and 3 h after injection of NH&l or NaHCOz 
Controls 
NH&l NaHC03 
lh 3h lh 3h 
PH 
Standard bicarbonate 
7.342kO.04 7.207t0.03 7.248t0.05 7.467t0.03 7.431t0.02 
03) 63) (7) (5) (5) 
23.7t1.6 15.8t1.2 17.2t4.5 32.3t1.4 31.4t1.7 
(7) (6) (6) (5) (5) 
Values are means ~fr SD; nos. in parentheses are nos. of animals. Values in all 4 treatment groups were significantly different from controls. 
350 
300 
15 10 
*I *I 
19 20 - 12 
U 
Control NH&l 7% co, 
monoxide (0.1%) and added carbon dioxide (7%) (means -+ SE); values 
Control NaHCO, 
in bars are nos. of animals; *significant difference from controls. 
FIG. 3. Serum EPO levels after 3-h exposure to carbon monoxide 
(0.1%) in animals treated with NH&l or NaHC03 or exposed to carbon 
control NH&I control NaHCO, 
FIG. 2. Serum EPO levels after 3-h exposure to 8% 0, and balance 
NP in mice treated with NH&l or NaHC03 (means t SE); values in 
bars are nos. of animals; *significant difference from controls. Respec- 
tive controls, treated with equimolar amounts of sodium chloride, were 
simultaneously exposed to hypoxia. 
ammonium chloride or sodium bicarbonate. The effect 
of this treatment on peripheral venous pH and standard 
bicarbonate levels is given in Table 1. It is obvious that 
they led to a marked metabolic acidosis and alkalosis, 
respectively, during the 3-h period investigated. 
To test any direct effect of metabolic acidosis and 
alkalosis on EPO in animals not exposed to hypoxia, 
EPO levels were measured in normoxic animals 3 h after 
application of ammonium chloride and sodium bicarbon- 
ate. Compared with control animals [2l t 1.9 (SE) mU/ 
ml; n = 14, values were slightly reduced after ammonium 
chloride [ 14.9 t 1.1 (SE) mu/ml; n = 151 and slightly 
elevated under sodium bicarbonate [24.4 t 2.4 (SE) mU/ 
ml; n = 151. However, only the difference between treat- 
ment groups reached statistical significance. 
To study the effect of metabolic acidosis and alkalosis 
on EPO formation induced by arterial hypoxia, ammo- 
nium chloride and sodium bicarbonate were injected to 
animals before a 3-h hypoxic exposure. The resulting 
EPO levels are depicted in Fig. 2. Metabolic acidosis 
significantly reduced EPO levels by 35%, whereas met- 
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FIG. 4. Serum EPO levels in mice determined 2 h after exposure to 
0- to 40-min hypoxia (8% 02; left) and EPO levels determined O-2.5 h 
after exposure to 15-min hypoxia (8% 02; right) (means t SE; n = 5- 
7). 
Effect of acid-base alterations on EPOproduction under 
carbon monoxide hypoxia. Figure 3 demonstrates the 
effect of metabolic acidosis, metabolic alkalosis, and 
respiratory acidosis (7% COa) on the increase in EPO 
abolic alkalosis had no effect. levels induced by carbon monoxide (0.1%). Similar to the 
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15 
control NH&l NH&I 
inj. before inj. after 
hypoxia hypoxia 
FIG. 5. Serum EPO levels determined 2 h after a hypoxic exposure 
of 15 min (8% 0,) in animals injected with NH&l before onset of 
hypoxia or immediately after termination of hypoxia (means t SE); 
values in bars are nos. of animals; *significant difference from controls. 
results obtained with hypoxic hypoxia, respiratory as 
well as metabolic acidosis led to significantly diminished 
serum EPO levels (58 and 62% of control values, respec- 
tively), whereas metabolic alkalosis did not affect EPO 
values. 
So far these results indicate that the observed suppres- 
sion of EPO levels in response to hypoxic or carbon 
monoxide hypoxia is related to a decrease in pH, irre- 
spective of the way by which it has been brought about, 
and is independent of changes in PCO~ or serum bicar- 
bonate levels. 
Effect of acidosis on induction of EPO formation and 
EPO synthesis. To assess whether the triggering of EPO 
formation and/or EPO synthesis is sensitive to a de- 
crease in pH, we aimed at roughly separating both pe- 
riods. We thereby define the trigger phase as time period 
during which hypoxia initiates the subsequent synthesis 
and release of EPO from the kidney. Under continuous 
hypoxia, when triggering and hormone synthesis overlap, 
EPO levels are known to be first elevated afer l-2 h (3, 
5, 6, 13, 25). To separate an initial phase of triggering, 
animals were exposed to shorter periods of hypoxia (8% 
0,; 5-40 min) and then returned into normoxic atmos- 
phere before determination of EPO levels to allow suffi- 
cient time for hormone production. Figure 4 (left) illus- 
trates that EPO levels determined 2 h after the end of 
hypoxic exposures are slightly elevated when hvpoxia 
had lasted for 10 min and increase with further prolon- 
gation of the hypoxic period. When EPO levels were 
determined between 1 and 2.5 h after a hypoxic stimu- 
lation of 15 min, mean EPO levels were maximally 
elevated after 2 h of normoxia and thereafter tended to 
decline again (Fig. 4, right). A combination of 15-min 
hvpoxia and 2-h normoxia was therefore used in the 
following experiment, designed to determine the possible 
effect of a decrease in pH on the different phases of 
hypoxia-induced EPO formation. As illustrated in Fig. 5, 
ammonium chloride led to a significant reduction of EPO 
levels when injected before the onset of hypoxia and was 
ineffective when injected immediately after the end of 
hypoxic exposure. 
DISCUSSION 
Following the observation that patients with carbon 
dioxide retention due to pulmonary insufficiency may 
fail to develop polycycthemia to a degree expected from 
the extent of their hypoxia (9, II), Faura and co-workers 
were, to our knowledge, the first to demonstrate a 
suppression of erythropoietic bioactivity when hypoxia 
was combined with hypercapnia (8). This effect was 
confirmed by several investigators (1, 3, 14, 20, 25, 26), 
and the concentration-dependent suppression of immu- 
noreactive EPO levels with increasing carbon dioxide 
tension found in the present study (Fig. 1) is qualitatively 
in accordance with these findings. However, quantita- 
tively, the effect of an increasing carbon dioxide concen- 
tration in the inhaled gas mixture appears more variable. 
In this study, we observed only a slight reduction by 
adding 5% COs, whereas other investigators reported 
more pronounced effects (25, 26), which may be related, 
for example, to different changes in ventilation. 
More important, the question arises about the mech- 
anisms by which hypercapnia may suppress EPO levels. 
From our finding that both respiratory and metabolic 
acidosis result in diminished EPO levels in response to 
hypoxia (Figs. 2 and 3), it may be concluded that this 
effect is directly related to a decrease in systemic pH 
rather than an increase in Pco~. Also, changes in plasma 
bicarbonate levels appear not to mediate the inhibitory 
effect of hypercapnia, since they are oppositely affected 
in respiratory and metabolic acidosis, and, in addition, 
metabolic alkalosis due to an increase in bicarbonate 
levels had no effect on EPO values (Figs. 2 and 3). This 
latter finding indicates furthermore that the relationship 
between EPO levels and pH is not consistent over the 
whole biological range of hydrogen ion concentrations. 
The respiratory alkalosis normally occuring under hy- 
poxia appears to enhance EPO levels, since its prevention 
by addition of 5% COZ reduces EPO titers, whereas any 
further alkalinization does not further enhance hypoxia- 
induced EPO values. 
The increase of serum EPO after hypoxia is deter- 
mined by as-yet-undefined mechanisms triggering an 
enhanced rate of EPO gene transcription, the subsequent 
increase in EPO synthesis, and, finally, the rate of hor- 
mone clearance. To determine, which of these parame- 
ters is sensitive to a decrease in pH, we attempted to 
roughly separate an initial trigger phase from a subse- 
quent phase of hormone synthesis and metabolism. An- 
imals were exposed to hypoxia for 15 min and allowed 
another 2 h in normoxia before determination of EPO 
levels (Fig. 4). Acidosis did only reduce EPO levels when 
initiated before the hypoxic pulse. When acidosis was 
applied immediately after termination of the hypoxic 
period. there was no change in EPO levels. From these 
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results, the conclusions may be drawn that the hypoxic 
trigger mechanisms of EPO formation are sensitive to 
acidosis, whereas neither the synthesis of EPO is inhib- 
ited nor the clearance rate enhanced by a decrease in 
PH. 
Because the trigger mechanisms of EPO formation are 
thought to be mainly determined by peripheral oxygen 
availability (cf. Ref. 5), it appears reasonable to consider 
possible pathways by which a decrease in systemic pH 
might alter this parameter. Because acidosis stimulates 
chemoreceptors, which in turn potentiate increased ven- 
tilation under hypoxia, animals subjected to hypercapnic 
hypoxia display higher arterial oxygen tensions and he- 
moglobin saturations than those exposed to normo- or 
hypocapnic hypoxia. Thus in previous studies in which 
rats or rabbits were exposed to hypoxia of a degree 
comparable with that in our experiments (7.58.8% O& 
the addition of 56% CO2 to the inspirated gas mixture 
was shown to increase arterial Paz by 9-16 mmHg (from 
26-36 mmHg under hypocapnic hypoxia to 42-45 mmHg 
after addition of COZ) (3, 14, 23, 25). Increased ventila- 
tion is, however, ineffective in increasing peripheral oxy- 
genation when diminished oxygen-carrying capacity 
causes the hypoxia. Nevertheless, we found also an in- 
hibitory effect of acidosis on EPO levels in animals 
exposed to carbon monoxide (Fig. 3), indicating that the 
increased ventilation is not the principal mechanism by 
which EPO formation is attenuated. This conclusion is 
in accordance with a previous study in which anesthe- 
tized rabbits were shown to develop less erythropoietic 
activity on hypercapnic hypoxia, although the increase 
in arterial oxygen content was prevented by controlled 
ventilation (1). 
The effect of hypercapnia on renal hemodynamics is 
variable, depending on the experimental conditions (4, 
19, 23), but renal blood flow and thereby renal oxygen 
supply may be increased (4). However, EPO formation 
has been shown to be relatively insensitive to alterations 
in renal perfusion (17), probably because changes in 
perfusion vary both oxygen supply and oxygen consump- 
tion in parallel (cf. Ref. 5). That acidosis inhibits EPO 
formation via a specific effect on renal function appears 
unlikely, because extrarenal EPO formation was also 
shown to be attenuated by hypercarbia (26). 
Several investigators have emphasized a possible role 
of alterations in the oxygen affinity of hemoglobin for 
peripheral tissue oxygenation and subsequently EPO 
formation (12-14,16,20,25). Thus an increase in oxygen 
affinity may enhance EPO formation in normoxic ani- 
mals (IZ), and hypoxic stimuli for EPO are associated 
with an increased oxygen affinity, whereas the inhibitory 
effect of acidosis is associated with decreased oxygen 
affinity (3, 14, 20, 25). Direct studies on the effect of 
oxygen affinity of hemoglobin on EPO formation suggest, 
however, that its relative role decreases with increasing 
degrees of hypoxia (12). Furthermore, a significant con- 
tribution of changes of the oxygen affinity of hemoglobin 
to the suppression of EPO formation by acidosis could 
not be substantiated in certain experimental settings. 
Miller and Howard (14), for example, found significant 
differences in plasma EPO concentrations between ane- 
mic rats exposed to normo- or hypercapnic hypoxia for 
18 h, despite no differences in arterial Paz, 0, saturation, 
or PSO values (14). 
Although these observations cast some doubt that a 
reduction in the oxygen affinity of hemoglobin is the sole 
mechanism by which a decrease in pH inhibits EPO 
formation, definite understanding of the role of increased 
peripheral oxygenation for the inhibition of EPO for- 
mation by acidosis will await identification and isolation 
of the cellular production sites, to determine their sen- 
sitivity to changes in pH. It is of interest that several 
reports demonstrated a protective effect of acidosis 
against hypoxic injury at a cellular level (2, 10, 18, 24), 
and one might speculate that this has bearings on the 
signals linking EPO formation to hypoxia. 
The antiserum used in the radioimmunoassay for erythropoietin was 
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